Literature DB >> 18422844

Asymptomatic infection by Leishmania infantum in blood donors from the Balearic Islands (Spain).

Cristina Riera1, Roser Fisa, Paulo López-Chejade, Teresa Serra, Enrique Girona, Mteresa Jiménez, José Muncunill, Matilde Sedeño, Martín Mascaró, Maria Udina, Montserrrat Gállego, Jaume Carrió, Alejandro Forteza, Montserrat Portús.   

Abstract

BACKGROUND: Visceral leishmaniasis (VL) caused by Leishmania infantum is a zoonotic disease endemic throughout the Mediterranean basin. The existence of asymptomatic human infection entails the risk of transmission by blood transfusion. STUDY DESIGN AND METHODS: The prevalence of Leishmania infection was studied in 1437 blood donors from the Balearic Islands (Majorca, Formentera, and Minorca) using immunologic (Western blot [WB] and delayed-type hypersensitivity [DTH]), parasitologic (culture), and molecular (nested polymerase chain reaction [PCR]) methods. In addition, the efficiency of leukoreduction by filtration to remove the parasite was tested by nested PCR in the red blood cell (RBC) units.
RESULTS: Leishmania antibodies were detected in 44 of the 1437 blood donors tested (3.1%). A sample of 304 donors from Majorca was selected at random. L. infantum DNA was amplified in peripheral blood mononuclear cells (PBMNCs) in 18 of the 304 (5.9%), and cultures were positive in 2 of the 304 (0.6%). DTH was performed on 73 of the 304 donors and was positive for 8 of them (11%). Of the 18 donors with positive L. infantum nested PCR, only 2 were seropositive. All the RBC samples tested (13 of 18) from donors with a positive PBMNC nested PCR yielded negative nested PCR results after leukodepletion.
CONCLUSIONS: Cryptic Leishmania infection is highly prevalent in blood donors from the Balearic Islands. DTH and L. infantum nested PCR appear to be more sensitive to detect asymptomatic infection than the serology. The use of leukodepletion filters appears to remove parasites from RBC units efficiently.

Entities:  

Mesh:

Year:  2008        PMID: 18422844     DOI: 10.1111/j.1537-2995.2008.01708.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  34 in total

1.  The utility of pathogen inactivation technology: a real-life example of Leishmania infantum inactivation in platelets from a donor with an asymptomatic infection.

Authors:  Teresa Jimenez-Marco; Cristina Riera; Roser Fisa; Enrique Girona-Llobera; Matilde Sedeño; Raymond P Goodrich; Alba Pujol; Carmen Guillen; Josep Muncunill
Journal:  Blood Transfus       Date:  2012-07-04       Impact factor: 3.443

2.  Evaluation of an enzyme-linked immunosorbent assay based on crude Leishmania histone proteins for serodiagnosis of human infantile visceral leishmaniasis.

Authors:  Sami Lakhal; Salima Mekki; Imène Ben-Abda; Mohamed Mousli; Fethi Amri; Karim Aoun; Aïda Bouratbine
Journal:  Clin Vaccine Immunol       Date:  2012-07-18

3.  Leishmania tropica in rock hyraxes (Procavia capensis) in a focus of human cutaneous leishmaniasis.

Authors:  Dalit Talmi-Frank; Charles L Jaffe; Abedelmajeed Nasereddin; Alon Warburg; Roni King; Milena Svobodova; Ofer Peleg; Gad Baneth
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

4.  Strategies for reducing the risk of transfusion-transmitted leishmaniasis in an area endemic for Leishmania infantum: a patient- and donor-targeted approach.

Authors:  Teresa Jimenez-Marco; Cristina Riera; Enrique Girona-Llobera; Carmen Guillen; Laura Iniesta; Magdalena Alcover; Diana Berenguer; Alba Pujol; Miriam Tomás-Pérez; Beatriz Cancino-Faure; Teresa Serra; Martín Mascaró; Joan Gascó; Roser Fisa
Journal:  Blood Transfus       Date:  2017-03-15       Impact factor: 3.443

5.  Anti-leishmania infantum IgG antibody avidity in visceral leishmaniasis.

Authors:  Monique Gomes Salles Tiburcio; Laís Anversa; Kelly Aparecida Kanunfre; Antonio Walter Ferreira; Virmondes Rodrigues Júnior; Luciana de Almeida Silva
Journal:  Clin Vaccine Immunol       Date:  2013-09-04

6.  Ultrasensitive real-time PCR for the clinical management of visceral leishmaniasis in HIV-Infected patients.

Authors:  Israel Molina; Roser Fisa; Cristina Riera; Vicenç Falcó; Aleix Elizalde; Fernando Salvador; Manuel Crespo; Adrian Curran; Paulo López-Chejade; Silvia Tebar; Santiago Pérez-Hoyos; Esteban Ribera; Albert Pahissa
Journal:  Am J Trop Med Hyg       Date:  2013-04-29       Impact factor: 2.345

7.  Serological Assessment for Leishmania donovani Infection in Blood Donors of Sunsari District, Dharan, Nepal.

Authors:  Suraj Timilsina; Narayan Raj Bhattarai; Basudha Khanal; Suman Rijal
Journal:  Indian J Hematol Blood Transfus       Date:  2015-01-18       Impact factor: 0.900

8.  Humoral and in vivo cellular immunity against the raw insect-derived recombinant Leishmania infantum antigens KMPII, TRYP, LACK, and papLe22 in dogs from an endemic area.

Authors:  Felicitat Todolí; Laia Solano-Gallego; Rafael de Juan; Pere Morell; Maria Del Carmen Núñez; Rodrigo Lasa; Silvia Gómez-Sebastián; José M Escribano; Jordi Alberola; Alhelí Rodríguez-Cortés
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

9.  Usefulness of the rK39-immunochromatographic test, direct agglutination test, and leishmanin skin test for detecting asymptomatic Leishmania infection in children in a new visceral leishmaniasis focus in Amhara State, Ethiopia.

Authors:  Endalamaw Gadisa; Estefanía Custodio; Carmen Cañavate; Luis Sordo; Zelalem Abebe; Javier Nieto; Carmen Chicharro; Abraham Aseffa; Lawrence Yamuah; Howard Engers; Javier Moreno; Israel Cruz
Journal:  Am J Trop Med Hyg       Date:  2012-05       Impact factor: 2.345

10.  Leishmania infantum chagasi in northeastern Brazil: asymptomatic infection at the urban perimeter.

Authors:  Iraci D Lima; Jose W Queiroz; Henio G Lacerda; Paula V S Queiroz; Nubia N Pontes; James D A Barbosa; Daniella R Martins; Jason L Weirather; Richard D Pearson; Mary E Wilson; Selma M B Jeronimo
Journal:  Am J Trop Med Hyg       Date:  2012-01       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.